Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2020-03-31 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
[기재정정]타법인주식및출자증권처분결정
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from a Korean company (Well Biotech) regarding the 'Decision to Dispose of Shares and Securities of Other Corporations'. It details the amendment of a previous disposal agreement, specifically changing the expected disposal date and payment schedule. This type of corporate action, involving the sale of assets or equity in other entities, falls under general regulatory announcements as it does not fit into specific categories like M&A (which usually implies a takeover or merger of the company itself) or share buybacks (which would be POS). Therefore, it is classified as a Regulatory Filing (RNS).
2020-03-31 Korean
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Independent Auditor's Report' (독립된 감사인의 감사보고서) for Well Biotech Co., Ltd. for the fiscal year ending December 31, 2019. It includes the auditor's opinion, management's responsibilities, and the full set of consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows) along with detailed notes. This is a formal audit report, not an annual report (10-K) which would include management discussion and analysis (MD&A) and business overview, nor is it an announcement (RPA). It fits the definition of an Audit Report (AR). FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a summary of the resolutions passed during the meeting, including financial statement approval, dividend status, and board composition. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2020-03-26 Korean
기타안내사항(안내공시)
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory announcement from Wellbiotech regarding the expiration of a lock-up period (protection period) for shares issued via a third-party capital increase. It does not fit into specific categories like M&A, dividends, or director dealings, and it is not a full financial report. As it is a general regulatory disclosure regarding share status, it falls under the RNS (Regulatory Filings) category.
2020-03-23 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (DART system) used when an entity acquires or changes a significant stake (typically 5% or more) in a listed company. This falls under the category of Major Shareholding Notification.
2020-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, financial highlights (assets, liabilities, equity, profit/loss), and auditor information for the fiscal year ending 2019. While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document. According to the classification rules, this fits the 'Audit Report / Information' (AR) category as it specifically reports on the audit opinion and financial results derived from the audit process. FY 2019
2020-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.